• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Model Number GSX0025A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 03/14/2022
Event Type  Injury  
Event Description
It was reported to gore a 25mm gore® cardioform septal occluder was implanted on (b)(6) 2021 to treat a patent foramen ovale.During a one year follow-up echocardiogram on (b)(6) 2022, thrombus was noted on the left side.The patient was started on eliquis and will be scheduled for transesophageal echocardiogram.It was reported that no thrombus were noted on the 1 month echocardiogram post implant.There is no reported history of clotting disorder.
 
Manufacturer Narrative
Patient weight was requested, but was not available.Imaging evaluation: the follow up imaging at one year showed a growth in the left atrium and on the tip of the left atrial eyelet.In the echo imaging provided, it appears that the device is in a stable and satisfactory position but this cannot be confirmed without fluoro imaging.The left atrial disc appears flat and well apposed to the atrial septum.The right atrial disc is also flat and well apposed to the atrial septum.The appearance of the vegetative growth on the left atrial eyelet and is consistent with a thrombus formation.The growth is protruding into the left atrium and appears to attach to the wall of the left atrium but does not appear larger in the echo images 1 week apart.From the imaging provided, the cause of the vegetative growth cannot be determined but it is suspected that it came from the tunnel track during implantation.This is suspected due to the thrombus only forming on the tip of the left atrial eyelet and not on the fabric.It is suspected that there was thrombus in the tunnel when crossing with the catheter and when advancing the left atrial disc, the thrombus was then pushed onto the left atrial eyelet.This cannot be confirmed without additional imaging.The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: thrombosis or thromboembolic event resulting in clinical sequelae.
 
Manufacturer Narrative
Additional information received: it was reported that on (b)(6) 2022, the patient was taken to surgery for a suspected thrombus.An atrial myxoma was found, no thrombus.The atrial myxoma tumor and the device were removed and the defect was closed.The patient was reported to be doing well.It was reported the physician confirmed it was an atrial myxoma and it was not present at time of device implant.The physician indicated the atrial myxoma is not device related.Medwatch report 2017233-2022-02857 is being retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14083954
MDR Text Key289067369
Report Number2017233-2022-02857
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631025
UDI-Public00733132631025
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/17/2023
Device Model NumberGSX0025A
Device Catalogue NumberGSX0025A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient SexFemale
-
-